kneat.com Stock Price

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.

Key Takeaways Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins. Partner programs and platform enhancements are set to expand market reach, integrating capabilities to increase revenue and profitability.